Erbozeta constantly invests in Research & Development, especially in the search for innovative active ingredients, in the development of new packaging solutions and in the adoption of new technologies and advanced equipment for the development of new high quality products.

Every year, our Product Manager staff develops more than 200 new formulations for numerous Italian and foreign companies.

Our products, thanks to the deepen research of raw materials and their high efficacy, are recognized and used by many health care facilities throughout Italy and in various countries abroad.

The R & D department is also in charge of Medical Affair, where the team regularly collaborates with internationally renowned specialists to carry out clinical studies on our products, able to demonstrate their maximum safety and effectiveness.

• Search for innovative ingredients
• Complete formulation development
• Re-formulation of existing products
• Choice and possible supply of packaging
• Manufacturing of pilot batches
• Technical and regulatory assistance
• Stability testing in different climate conditions
• Artwork management and graphic design

The Erbozeta Group operates in constant cooperation with the scientific community in order to provide Food Supplements and Medical Devices safe and able to meet the therapeutic needs of the market.

Medical Affairs plays an important role in the operations of Erbozeta Group. Many activities of clinical research carried out in recent years have been coordinated within the company through the supervision of Medical Affairs, whose task is to study and recommend clinical guidelines for the development of products.

To this end, the Medical Affairs team collaborates continuously with universities and hospital centers during all phases of the development of clinical trials. In recent years, we want to emphasize Erbozeta’s collaborations with leading universities and hospitals to perform clinical trials in various therapeutic areas.

Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial
Arrigo F.G. Cicero, Martina Rosticci, Martino Morbini, Marcella Cagnati, Elisa Grandi, Angelo Parini, Claudio Borghi

Efficacy and tolerability of a combined lipid-lowering nutraceutical on cholesterolemia, hs-crp level and endothelial function in moderately hypercholesterolemic subjects
A.F. Cicero, A. Colletti, M. Rosticci, E. Grandi e C. Borghi

Efficacy of a combination of fixed doses of serratiopeptidases, bromelain and methylsulfonylmethane in inflammatory joint diseases
Martin-Martin LS, De Burgos-Mota M, Apa M, Pierangeli D,  Ragno A e Silvestri A

Tyndallized lactic ferments: new possible therapies in treating vaginitis
Claudia Guaraldi, Michele Costantino, Demetrio Costantino

Cellular Rhinitis: A Therapeutic Proposal 
A Macchi, F De Bernardi1, A Peirolo and D Simoncini

Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients
Tommaso Cai, Daniele Tiscione, Luca Gallelli, Paolo Verze, Alessandro Palmieri, Vincenzo Mirone, Riccardo Bartoletti, Gianni Malossini

Cough therapy in children with plant-based products: a prospective observational clinical study
Antonello Arrighi

A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters
G. Derosa, A. Bonaventura, L. Bianchi, D. Romano, A. D’angelo, E. Fogari E P. Maffioli

Combined use of bromelain and N-acetylcysteine in the treatment of acute otitis media
Roberto Bruno

A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters
G. Derosa, A. Bonaventura, L. Bianchi, D. Romano, A. D’Angelo, E. Fogari e P. Maffioli

Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study
Ludovico Abenavoli, Marta Greco, Natasa Milic, Francesca Accattato, Daniela Foti, Elio Gulletta e Francesco Luzza